rs755948940
×
Entrez Id:
4597
Gene Symbol:
MVD
MVD
POROKERATOSIS 7, MULTIPLE TYPES
0.800
GeneticVariation
UNIPROT
Genomic variations of the mevalonate pathway in porokeratosis.
26202976
2015
rs761991070
×
Entrez Id:
4597
Gene Symbol:
MVD
MVD
POROKERATOSIS 7, MULTIPLE TYPES
0.800
GeneticVariation
UNIPROT
Genomic variations of the mevalonate pathway in porokeratosis.
26202976
2015
rs755948940
×
Entrez Id:
4597
Gene Symbol:
MVD
MVD
POROKERATOSIS 7, MULTIPLE TYPES
0.800
GeneticVariation
UNIPROT
Human mevalonate diphosphate decarboxylase: characterization, investigation of the mevalonate diphosphate binding site, and crystal structure.
18823933
2008
rs761991070
×
Entrez Id:
4597
Gene Symbol:
MVD
MVD
POROKERATOSIS 7, MULTIPLE TYPES
0.800
GeneticVariation
UNIPROT
Human mevalonate diphosphate decarboxylase: characterization, investigation of the mevalonate diphosphate binding site, and crystal structure.
18823933
2008
rs755948940
×
Entrez Id:
4597
Gene Symbol:
MVD
MVD
POROKERATOSIS 7, MULTIPLE TYPES
C
0.800
CausalMutation
CLINVAR
rs761991070
×
Entrez Id:
4597
Gene Symbol:
MVD
MVD
POROKERATOSIS 7, MULTIPLE TYPES
G
0.800
CausalMutation
CLINVAR
rs3794625
MVD;SNAI3-AS1
Finding of Mean Corpuscular Hemoglobin
0.700
GeneticVariation
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
rs200033380
×
Entrez Id:
4597
Gene Symbol:
MVD
MVD
POROKERATOSIS 7, MULTIPLE TYPES
0.700
GeneticVariation
UNIPROT
Genomic variations of the mevalonate pathway in porokeratosis.
26202976
2015
rs546127665
×
Entrez Id:
1535;4597
Gene Symbol:
CYBA;MVD
CYBA;MVD
POROKERATOSIS 7, MULTIPLE TYPES
0.700
GeneticVariation
UNIPROT
Genomic variations of the mevalonate pathway in porokeratosis.
26202976
2015
rs776358937
×
Entrez Id:
4597
Gene Symbol:
MVD
MVD
POROKERATOSIS 7, MULTIPLE TYPES
0.700
GeneticVariation
UNIPROT
Genomic variations of the mevalonate pathway in porokeratosis.
26202976
2015
rs776684503
×
Entrez Id:
4597
Gene Symbol:
MVD
MVD
POROKERATOSIS 7, MULTIPLE TYPES
0.700
GeneticVariation
UNIPROT
Genomic variations of the mevalonate pathway in porokeratosis.
26202976
2015
rs200033380
×
Entrez Id:
4597
Gene Symbol:
MVD
MVD
POROKERATOSIS 7, MULTIPLE TYPES
0.700
GeneticVariation
UNIPROT
Human mevalonate diphosphate decarboxylase: characterization, investigation of the mevalonate diphosphate binding site, and crystal structure.
18823933
2008
rs546127665
×
Entrez Id:
1535;4597
Gene Symbol:
CYBA;MVD
CYBA;MVD
POROKERATOSIS 7, MULTIPLE TYPES
0.700
GeneticVariation
UNIPROT
Human mevalonate diphosphate decarboxylase: characterization, investigation of the mevalonate diphosphate binding site, and crystal structure.
18823933
2008
rs776358937
×
Entrez Id:
4597
Gene Symbol:
MVD
MVD
POROKERATOSIS 7, MULTIPLE TYPES
0.700
GeneticVariation
UNIPROT
Human mevalonate diphosphate decarboxylase: characterization, investigation of the mevalonate diphosphate binding site, and crystal structure.
18823933
2008
rs776684503
×
Entrez Id:
4597
Gene Symbol:
MVD
MVD
POROKERATOSIS 7, MULTIPLE TYPES
0.700
GeneticVariation
UNIPROT
Human mevalonate diphosphate decarboxylase: characterization, investigation of the mevalonate diphosphate binding site, and crystal structure.
18823933
2008
rs144010349
×
Entrez Id:
4597
Gene Symbol:
MVD
MVD
POROKERATOSIS 7, MULTIPLE TYPES
0.700
GeneticVariation
UNIPROT
rs770939767
×
Entrez Id:
4597
Gene Symbol:
MVD
MVD
POROKERATOSIS 7, MULTIPLE TYPES
0.700
GeneticVariation
UNIPROT
rs16966671
×
Entrez Id:
1535;4597
Gene Symbol:
CYBA;MVD
CYBA;MVD
Anthracosis
0.010
GeneticVariation
BEFREE
No statistically significant difference was demonstrated in either the allele or genotype frequencies of the other four examined SNPs (rs13306296, rs4673, rs9932581, and rs16966671 ) between the CWP group and dust-exposed control group (all p > .05).
30654669
2019
rs9932581
×
Entrez Id:
1535;4597
Gene Symbol:
CYBA;MVD
CYBA;MVD
Kidney Diseases
0.010
GeneticVariation
BEFREE
The major G-allele of rs9932581 was associated with the incidence of renal events defined as new cases of microalbuminuria or the progression to a more severe stage of nephropathy during follow-up (HR 1.59, 95% CI 1.17-2.18, P=0.003) in SURGENE.
25862415
2015